Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
A multi-center, randomized, double-blind, active-controlled, parallel group, phase IV clinical trial to investigate the effect on blood glucose of evogliptin after oral administration in patients with type 2 diabetes
Epistemonikos ID: b9a990b921042e53b48dd52977497f439af14c92
First added on: May 20, 2024